RECRUITING · INTERVENTIONAL · TREATMENT study · Renal Cancer · Phase 2 · Enrollment 17 · Sponsor: University of Colorado, Denver
ClinicalTrials.gov published a clinical update in Infectious Disease on 13 Apr 2026. The item focuses on Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus. Open the detail page to review the full original feed content.